3(top 5%)
papers
14(top 5%)
citations
2(top 5%)
h-index
2(top 5%)
g-index
3
all documents
15
doc citations
15
citing journals

Top Articles

#TitleJournalYearCitations
1p53‐Based strategy to reduce hematological toxicity of chemotherapy: A proof of principle studyMolecular Oncology20169
2Phase I/II, open-label, multiple ascending dose trial of AGEN2034, an anti–PD-1 monoclonal antibody, in advanced solid malignancies: Results of dose escalation in advanced cancer and expansion cohorts in subjects with relapsed/refractory cervical cancerAnnals of Oncology20186
3Phase I, open-label ascending dose trial of anti–CTLA-4 monoclonal antibody AGEN1884 in advanced solid malignancies, with expansion to patients refractory to recent anti–PD-1/PD-L1 therapyAnnals of Oncology20180